Michael Petusky analyst BARRINGTON

Currently, out of the existing stock ratings of Michael Petusky - 170 which are a Buy (85.86%), 27 which are a Hold (13.64%), 1 which are a Sell (0.51%)

Michael Petusky

Work Performance Price Targets & Ratings Chart

Analyst Michael Petusky works at BARRINGTON and is covering Healthcare, Consumer Defensive sectors with 434 price targets and ratings displayed on 15 stocks.

Michael Petusky's average stock forecast success ratio is 65.08% with an average time for price targets to be met of 228.67 days.

Most recent stock forecast was given on MMSI, Merit Medical Systems at 16-Aug-2023.

Wall Street Analyst Michael Petusky

Analyst best performing recommendations are on ANIK (ANIKA THERAPEUTICS).
The best stock recommendation documented was for ANIK (ANIKA THERAPEUTICS) at 11/9/2022. The price target of $31 was fulfilled within 1 day with a profit of $1.4 (4.73%) receiving and performance score of 47.3.

Average potential price target upside

ANIK Anika Therapeutics HAE Haemonetics HSIC Henry Schein LMAT LeMaitre Vascular LNDC MMSI Merit Medical Systems OPK OPKO Health PRMW Primo Water TVTY Tivity Health USPH U.S. Physical Therapy XRAY DENTSPLY SIRONA MODV OPCH SRDX Surmodics VAR

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$6.22 (34.98%)

1 months 7 days ago

11/13 (84.62%)

$3.4 (9.62%)




$17.22 (96.85%)


1 years 6 months 11 days ago

0/2 (0%)

$12.77 (40.00%)



$28.22 (158.72%)


1 years 10 months 3 days ago

0/2 (0%)

$5.38 (13.25%)



$47.22 (265.58%)


3 years 8 months 11 days ago

5/6 (83.33%)

$5.42 (12.17%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Michael Petusky is most bullish on?

Potential upside of $35.91 has been obtained for SRDX (SURMODICS)

Which stock is Michael Petusky is most reserved on?

Potential downside of $0.36 has been obtained for OPK (OPKO HEALTH)

What Year was the first public recommendation made by Michael Petusky?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart